Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individual with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.

Postprandial hyperglycaemia ups diabetic retinopathy risk

17 Dec 2019

Postprandial hyperglycaemia during clinical visits may predict diabetic retinopathy (DR) among patients with type 2 diabetes (T2D), a new study has shown.

Researchers performed a retrospective cohort analysis of 323 participants with 1–2-hour postbreakfast mean blood glucose (1–2h-PBBG) measurements and 406 participants with the same data 1–2 hours postlunch (1–2h-PLBG); another group of 487 patients with both measurements (1–2h-PBLBG) was also included. The endpoint was mild-to-moderate nonproliferative DR.

In the group with both postbreakfast and postlunch blood glucose measurements, 145 patients developed DR over a median follow-up of 6.9 years. Those who had had T2D for a longer time (p=0.0001), had higher body mass index (BMI; p=0.014) and had a higher mean 1–2h-PBLBG level (p<0.0001) were significantly more likely to develop the complication.

The same was true for the 1–2h-PBBG group, where 92 patients developed DR over a median follow-up of 7.5 years. An elevated mean 1–2h-PBBG concentration (p<0.0001), greater BMI (p=0.04) and longer diabetes duration (p=0.014) all significantly increased the risk of DR.

Postprandial glucose was likewise a significant risk factor for DR in the 1–2h-PLBG group (p=0.0005), along with T2D duration (p=0.002) and glycated haemoglobin (HbA1c) level (p<0.0001). In this group, 126 patients developed DR over the 6.7-year median follow-up.

The present study found that “even with well-controlled HbA1c levels, correcting postprandial hyperglycaemia is important for preventing DR, especially in middle-aged adults with T2D,” said the researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individual with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.